Materials and methods for the treatment of gastroesophageal reflux disease
OwnerPascal Druzgala, Peter G. Milner +2inventors
InventorsPascal Druzgala, Peter G. Milner, Jurg Pfister, Cyrus Becker
Life of this patent
Estimating the term…
Loading patent…
OwnerPascal Druzgala, Peter G. Milner +2inventors
InventorsPascal Druzgala, Peter G. Milner, Jurg Pfister, Cyrus Becker
Estimating the term…
The subject invention provides novel compounds and compositions for the safe and effective treatment of gastroesophageal reflux and related conditions. In a preferred embodiment, the compositions of the subject invention comprise esterified cisapride derivatives. These compositions possess potent activity in treating gastroesophageal reflux disease and substantially reduce adverse effects associated with the administration of cisapride. These adverse effects include, but are not limited to, diarrhea, abdominal cramping and elevations of blood pressure and heart rate.
A method for treating a disease state which can be improved by stimulating the motility of the gastrointestinal system wherein said method comprises administering, to an individual in need of such a treatment, a compound, or an analog or salt thereof, wherein said compound has the following structure:
A compound, or an analog or salt thereof, wherein said compound has the following structure:
A method for treating a condition which is susceptible to treatment by modulation of serotonergic systems wherein said method comprises administering to an individual in need of such treatment, an effective amount of a compound, or an analog or salt thereof, wherein said compound has the following structure:
Dependencies are inferred from the claim text.